Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com.
Company Details
- Employees
- 119
- Founded
- -
- Address
- 302 East Pettigrew Street, Durham,north Carolina 27701,united States
- Phone
- (919) 314-5512
- pa****@****ces.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- precisionbiosciences.com
- Keywords
- Gene Editing and Gene Therapy.
- HQ
- Durham, North Carolina
Precision Biosciences, Inc. Questions
Precision Biosciences, Inc.'s helpline number is (919) 314-5512
Precision Biosciences, Inc.'s website is precisionbiosciences.com
Precision Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/precision-biosciences-inc-
Precision Biosciences, Inc. has
119 employees.
View email and phone details for 119
employees at Precision Biosciences, Inc..
Precision Biosciences, Inc.'s industry is
Biotechnology Research
Precision Biosciences, Inc.'s top competitors are
Kriya Therapeutics, Inc.,
Imugene Limited,
Kbi Biopharma,
Biogen,
Tune Therapeutics,
Askbio Inc.,
Bluerock Therapeutics,
Bioagilytix,
Beam Therapeutics,
Vertex Pharmaceuticals.
Precision Biosciences, Inc.'s support email address is partner@precisionbiosciences.com
Precision Biosciences, Inc.'s categories are Biotechnology Research
Precision Biosciences, Inc.'s founding year is 2006
